117 related articles for article (PubMed ID: 8889055)
1. Use of ELISA for in vitro potency test of rabies vaccines for animal use.
Gamoh K; Senda M; Itoh O; Muramatsu M; Hirayama N; Koike R; Endoh YS; Minamoto N
Biologicals; 1996 Jun; 24(2):95-101. PubMed ID: 8889055
[TBL] [Abstract][Full Text] [Related]
2. Expression of the nucleoprotein gene of rabies virus for use as a diagnostic reagent.
He Y; Gao D; Zhang M
J Virol Methods; 2006 Dec; 138(1-2):147-51. PubMed ID: 17034869
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines.
Rooijakkers E; Groen J; Uittenbogarrd J; van Herwijnen J; Osterhaus A
Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of a competitive ELISA for estimation of rabies neutralizing antibodies after post-exposure rabies vaccination in humans.
Muhamuda K; Madhusudana SN; Ravi V
Int J Infect Dis; 2007 Sep; 11(5):441-5. PubMed ID: 17321182
[TBL] [Abstract][Full Text] [Related]
5. A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture.
Nagarajan T; Reddy GS; Mohana Subramanian B; Rajalakshmi S; Thiagarajan D; Tordo N; Jallet C; Srinivasan VA
Biologicals; 2006 Mar; 34(1):21-7. PubMed ID: 16188454
[TBL] [Abstract][Full Text] [Related]
6. Development of a qualitative indirect ELISA for the measurement of rabies virus-specific antibodies from vaccinated dogs and cats.
Cliquet F; McElhinney LM; Servat A; Boucher JM; Lowings JP; Goddard T; Mansfield KL; Fooks AR
J Virol Methods; 2004 Apr; 117(1):1-8. PubMed ID: 15019254
[TBL] [Abstract][Full Text] [Related]
7. Multicenter comparative study of a new ELISA, PLATELIA RABIES II, for the detection and titration of anti-rabies glycoprotein antibodies and comparison with the rapid fluorescent focus inhibition test (RFFIT) on human samples from vaccinated and non-vaccinated people.
Feyssaguet M; Dacheux L; Audry L; Compoint A; Morize JL; Blanchard I; Bourhy H
Vaccine; 2007 Mar; 25(12):2244-51. PubMed ID: 17224214
[TBL] [Abstract][Full Text] [Related]
8. Competitive ELISA using a rabies glycoprotein-transformed cell line to semi-quantify rabies neutralizing-related antibodies in dogs.
Zhang S; Liu Y; Zhang F; Hu R
Vaccine; 2009 Mar; 27(15):2108-13. PubMed ID: 19356613
[TBL] [Abstract][Full Text] [Related]
9. G-protein based ELISA as a potency test for rabies vaccines.
Chabaud-Riou M; Moreno N; Guinchard F; Nicolai MC; Niogret-Siohan E; Sève N; Manin C; Guinet-Morlot F; Riou P
Biologicals; 2017 Mar; 46():124-129. PubMed ID: 28214171
[TBL] [Abstract][Full Text] [Related]
10. A novel site-II directed glycoprotein estimation ELISA to aid rabies vaccine manufacture for veterinary and human use.
Abhinay G; Dessain S; Srikanth A; Senthilkumar RL; Vidyasagar P; Praveen A; Chandrasekhar Reddy RV; Swapna Reddy E; Rajendra L
Vaccine; 2014 Jan; 32(2):209-13. PubMed ID: 24262315
[TBL] [Abstract][Full Text] [Related]
11. A relevant in vitro ELISA test in alternative to the in vivo NIH test for human rabies vaccine batch release.
Gibert R; Alberti M; Poirier B; Jallet C; Tordo N; Morgeaux S
Vaccine; 2013 Dec; 31(50):6022-9. PubMed ID: 24161572
[TBL] [Abstract][Full Text] [Related]
12. An ELISA-based antigenicity test of rabies recombinant glycoprotein cannot predict its protective potency in vivo.
Volokhov DV; Fry AM; Furtak V; Jones RM; Musiychuk K; Norikane J; Green BJ; Srinivas GB; Streatfield SJ; Yusibov V
Mol Cell Probes; 2022 Jun; 63():101815. PubMed ID: 35364264
[TBL] [Abstract][Full Text] [Related]
13. A novel in vitro ELISA for estimation of glycoprotein content in human rabies vaccines.
Aavula SM; Abhinay G; Nimmagadda SV; Maithal K
J Immunoassay Immunochem; 2017; 38(4):400-410. PubMed ID: 28436708
[TBL] [Abstract][Full Text] [Related]
14. Use of the single radial immunodiffusion test as a replacement for the NIH mouse potency test for rabies vaccine.
Fitzgerald EA; Needy CF
Dev Biol Stand; 1986; 64():73-9. PubMed ID: 3098606
[TBL] [Abstract][Full Text] [Related]
15. The use of alternatives to animal tests in developing countries.
Hong HA; Hendriks J
Dev Biol Stand; 1999; 101():209-14. PubMed ID: 10566795
[TBL] [Abstract][Full Text] [Related]
16. Quantitative determination of rabies antigen by ELISA.
van der Marel P; van Wezel AL
Dev Biol Stand; 1981; 50():267-75. PubMed ID: 7341294
[TBL] [Abstract][Full Text] [Related]
17. The rabies peripheral challenge test: more accurate determination of vaccine potency.
Wunderli PS; Dreesen DW; Miller TJ; Baer GM
Vaccine; 2006 Nov; 24(49-50):7115-23. PubMed ID: 16919854
[TBL] [Abstract][Full Text] [Related]
18. A versatile in vitro ELISA test for quantification and quality testing of infectious, inactivated and formulated rabies virus used in veterinary monovalent or combination vaccine.
Sigoillot-Claude C; Battaglio M; Fiorucci M; Gillet D; Vimort AS; Giraud Y; Laurent S; Vaganay A; Poulet H
Vaccine; 2015 Jul; 33(32):3843-9. PubMed ID: 26144898
[TBL] [Abstract][Full Text] [Related]
19. Zonal centrifuge purification of human rabies vaccine obtained on bovine fetal kidney cells. Biological results.
Atanasiu P; Tsiang H; Reculard P; Aguilon F; Lavergne M; Adamovicz P
Dev Biol Stand; 1978; 40():35-44. PubMed ID: 680400
[TBL] [Abstract][Full Text] [Related]
20. A quantitative indirect ELISA to monitor the effectiveness of rabies vaccination in domestic and wild carnivores.
Servat A; Feyssaguet M; Blanchard I; Morize JL; Schereffer JL; Boue F; Cliquet F
J Immunol Methods; 2007 Jan; 318(1-2):1-10. PubMed ID: 17166510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]